Vaxdyn
Biotech developing multi-pathogen vaccines to prevent antibiotic-resistant infections (AMR). Platform targeting over 1M deaths/year from drug-resistant bacteria.
Details
- Status
- Active
- Score
- 1.3
- Funding
- €14.5M
- Founded
- 2011
- Headcount
- 1-10
- City
- Sevilla